Holcim guidance rises as third-quarter profit beats forecasts

Holcim guidance for 2026 rose for the second time this year on October 23, after stronger demand and cost discipline helped third-quarter recurring operating profit beat expectations. The Swiss building-materials company now expects organic growth in recurring earnings before interest and taxes of 10%–12%, compared with its previous 10% estimate.

Key Takeaways

• Third-quarter recurring EBIT reached CHF 976 million, exceeding the CHF 946.7 million analyst estimate.
• Management expects about 5% organic sales growth in 2026 alongside the higher profit-growth target.
• Lower-carbon products gained sales share, while the planned Fermacell acquisition remains subject to approvals.

Table of Contents

• Holcim guidance follows stronger quarterly earnings
• Lower-carbon products gain a larger sales share
• Regional figures show why growth measures matter
• Fermacell agreement expands the acquisition pipeline
• Conclusion

Holcim guidance follows stronger quarterly earnings

Holcim’s third-quarter 2026 results showed recurring EBIT rising 16.8% in Swiss francs to CHF 976 million. Organic recurring EBIT growth was 12.2%, distinguishing the underlying growth measure from the reported currency-based increase.

Quarterly net sales rose 15.5% in Swiss francs to CHF 4.662 billion, with organic growth of 5.1%. The recurring EBIT margin increased to 20.9% from 20.7% a year earlier, showing that operating profit grew slightly faster than revenue.

Chief Executive Miljan Gutovic attributed the performance to increased customer demand, strict cost discipline and operational execution. Shares gained as much as 6% following the announcement; that was an intraday move, not a closing return.

Alongside its upgraded profit outlook, management expects a further increase in the full-year recurring EBIT margin and free cash flow of around CHF 2 billion. These remain company targets rather than completed results.

Lower-carbon products gain a larger sales share

Holcim said demand for its sustainable offering continued to increase. In the first nine months of 2026, ECOPlanet low-carbon cement accounted for 43% of cement net sales, up from 36% in the comparable 2025 period.

ECOPact low-carbon concrete represented 33% of ready-mix net sales, compared with 32% a year earlier. Both comparisons use a constant scope, excluding the year-over-year effects of acquisitions and divestments.

Alternative fuels are another part of the cost strategy. Gutovic said their use in Europe exceeded 70% in September and that he aims to reach 90% by 2030. He also warned that higher input costs would affect pricing in 2027, with customer discussions about increases already under way.

Regional figures show why growth measures matter

Germany, Greece, Romania, Spain and Switzerland led European sales development. Europe’s third-quarter external sales increased 17.0% in Swiss francs and 3.9% organically, while Latin America recorded increases of 36.7% and 6.3%, respectively.

Asia, the Middle East and Africa presented a different picture: external sales fell 5.5% in Swiss francs but grew 6.8% organically. The reported decline therefore did not represent a contraction on the company’s organic measure.

Holcim pointed to a strong European infrastructure pipeline as support for its outlook. That prospective demand sits alongside continuing energy and input-cost pressures, rather than eliminating them.

Fermacell agreement expands the acquisition pipeline

Holcim completed 10 acquisitions and one divestment in the first nine months of 2026. Separately, it signed an agreement in August to acquire Fermacell from James Hardie Industries.

Fermacell would expand Holcim’s European walling, flooring and fire-protection portfolio. The transaction has not closed: it remains subject to customary conditions and regulatory clearances, with completion expected in the first half of 2027.

Conclusion

The next test for Holcim guidance is delivery against the upgraded 2026 profit-growth range, margin target and cash-flow outlook. The Fermacell acquisition provides a separate milestone, with closing expected in the first half of 2027, subject to approvals and other conditions.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.